Description
Rendex was a European venture capital firm based in Antwerp, Belgium. The firm focused on first round to pre-IPO private equity investments in the information and communication technology (ICT) and in life sciences sectors, but also manages a historical portfolio of diversified investments.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Vernalis | 29-Apr-2009 | Secondary Transaction - Private | Drug Discovery | Profitable | ||
00000 0000000 | 25-Aug-2004 | 00000 00000 | 00.000 | Application Software | Generating Revenue | |
000000 | 24-Mar-2003 | 00000 00000 | 00.000 | Electronics (B2C) | Out of Business | |
00000 000000000000 | 22-Jul-2002 | 00000 00000 | 000.00 | Application Specific Semiconductors | Generating Revenue | |
00000000000 | 12-Apr-2002 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
0000:00 | 09-Jan-2002 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | |
0000 000000000 000 | 30-Jul-2001 | 00000 00000 | 000.00 | Media and Information Services (B2B) | Generating Revenue | |
0000000 0000000000 | 01-May-2001 | 00000 00000 | 00.00 | Drug Delivery | Out of Business | |
Hybrigenics | 01-Oct-2000 | Early Stage VC | 0000 | Biotechnology | Generating Revenue/Not Profitable | |
Devgen | 19-Jul-2000 | Early Stage VC | 00.000 | Agricultural Chemicals | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Vernalis | 10-Oct-2018 | Merger/Acquisition | 0000 |
00000 0000000 | 27-Nov-2012 | 000000000000000000 | |
0000000 | 16-Apr-2010 | 000000000000000000 | 000.00 |
00000 0000000 | 26-Mar-2008 | 000000000000000000 | |
00000000000 | 17-Dec-2007 | 000 | 000 |
000000 00000000000 | 01-Dec-2007 | 000000000 00000000 | |
000 000000 00000 | 09-Mar-2007 | 0000000000 | |
00000000 000000000 | 18-May-2006 | 0000000000 | |
Business Architects International | 13-Jan-2006 | Buyout/LBO | 00.000 |
Devgen | 05-Jun-2005 | IPO | 000.00 |